XML 66 R56.htm IDEA: XBRL DOCUMENT
v3.22.2.2

CORRECTION OF PREVIOUSLY ISSUED QUARTERLY FINANCIAL INFORMATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Accounting Changes and Error Corrections [Abstract] |
Schedule of Error Corrections and Prior Period Adjustments | The following tables present the effect of correcting these accounting errors on the Company’s previously issued financial statements:
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Year Ended December 31, 2021 |  | Year Ended December 31, 2020 |  | Year Ended December 31, 2019
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 4,251 |  |  | $ | (20) |  |  | $ | 4,231 |  |  | $ | 3,342 |  |  | $ | (3) |  |  | $ | 3,339 |  |  | $ | 4,029 |  |  | $ | (7) |  |  | $ | 4,022 |
Cost of products sold |  | 1,890 |  |  | (6) |  |  | 1,884 |  |  | 1,685 |  |  | (2) |  |  | 1,683 |  |  | 1,864 |  |  | (6) |  |  | 1,858 |
Gross profit |  | 2,361 |  |  | (14) |  |  | 2,347 |  |  | 1,657 |  |  | (1) |  |  | 1,656 |  |  | 2,165 |  |  | (1) |  |  | 2,164 |
Selling, general, and administrative expenses |  | 1,551 |  |  | — |  |  | 1,551 |  |  | 1,312 |  |  | (10) |  |  | 1,302 |  |  | 1,580 |  |  | 7 |  |  | 1,587 |
Research and development expenses |  | 171 |  |  | — |  |  | 171 |  |  | 123 |  |  | — |  |  | 123 |  |  | 143 |  |  | — |  |  | 143 |
Goodwill impairment |  | — |  |  | — |  |  | — |  |  | 157 |  |  | — |  |  | 157 |  |  | — |  |  | — |  |  | — |
Restructuring and other costs |  | 17 |  |  | — |  |  | 17 |  |  | 77 |  |  | — |  |  | 77 |  |  | 81 |  |  | — |  |  | 81 |
Operating income (loss) |  | 622 |  |  | (14) |  |  | 608 |  |  | (12) |  |  | 9 |  |  | (3) |  |  | 361 |  |  | (8) |  |  | 353 |
Other income and expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  | 55 |  |  | — |  |  | 55 |  |  | 47 |  |  | (1) |  |  | 46 |  |  | 28 |  |  | (1) |  |  | 27 |
Other expense (income), net |  | 8 |  |  | — |  |  | 8 |  |  | 1 |  |  | — |  |  | 1 |  |  | (12) |  |  | — |  |  | (12) |
Income (loss) before income taxes |  | 559 |  |  | (14) |  |  | 545 |  |  | (60) |  |  | 10 |  |  | (50) |  |  | 345 |  |  | (7) |  |  | 338 |
Provision for income taxes |  | 138 |  |  | (4) |  |  | 134 |  |  | 23 |  |  | — |  |  | 23 |  |  | 82 |  |  | — |  |  | 82 |
Net income (loss) |  | 421 |  |  | (10) |  |  | 411 |  |  | (83) |  |  | 10 |  |  | (73) |  |  | 263 |  |  | (7) |  |  | 256 |
Less: Net income (loss) attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income (loss) attributable to Dentsply Sirona |  | $ | 421 |  |  | $ | (10) |  |  | $ | 411 |  |  | $ | (83) |  |  | $ | 10 |  |  | $ | (73) |  |  | $ | 263 |  |  | $ | (7) |  |  | $ | 256 |
Net income (loss) per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 1.93 |  |  | $ | (0.05) |  |  | $ | 1.88 |  |  | $ | (0.38) |  |  | $ | 0.05 |  |  | $ | (0.33) |  |  | $ | 1.18 |  |  | $ | (0.03) |  |  | $ | 1.15 |
Diluted |  | $ | 1.91 |  |  | $ | (0.04) |  |  | $ | 1.87 |  |  | $ | (0.38) |  |  | $ | 0.05 |  |  | $ | (0.33) |  |  | $ | 1.17 |  |  | $ | (0.03) |  |  | $ | 1.14 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Year Ended December 31, 2021 |  | Year Ended December 31, 2020 |  | Year Ended December 31, 2019
(in millions) | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net income (loss) | $ | 421 |  |  | (10) |  |  | $ | 411 |  |  | $ | (83) |  |  | 10 |  |  | $ | (73) |  |  | $ | 263 |  |  | (7) |  |  | $ | 256 |
Pension liability adjustments | 26 |  |  | — |  |  | 26 |  |  | (13) |  |  | — |  |  | (13) |  |  | (36) |  |  | 10 |  |  | (26) |
Total other comprehensive (loss) income | (130) |  |  | — |  |  | (130) |  |  | 137 |  |  | 2 |  |  | 139 |  |  | (120) |  |  | 10 |  |  | (110) |
Total comprehensive income | 291 |  |  | (10) |  |  | 281 |  |  | 54 |  |  | 12 |  |  | 66 |  |  | 143 |  |  | 3 |  |  | 146 |
Comprehensive income attributable to Dentsply Sirona | 293 |  |  | (10) |  |  | 283 |  |  | 53 |  |  | 12 |  |  | 65 |  |  | 142 |  |  | 3 |  |  | 145 |
CONSOLIDATED BALANCE SHEETS
| December 31, 2021 |  | December 31, 2020
(in millions) | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Accounts and notes receivable-trade, net | $ | 747 |  |  | $ | 3 |  |  | $ | 750 |  |  | $ | 673 |  |  | $ | (6) |  |  | $ | 667 |
Inventories, net | 504 |  |  | 11 |  |  | 515 |  |  | 466 |  |  | 10 |  |  | 476 |
Prepaid expenses and other current assets | 247 |  |  | 1 |  |  | 248 |  |  | 214 |  |  | 3 |  |  | 217 |
Total Current Assets | 1,837 |  |  | 15 |  |  | 1,852 |  |  | 1,791 |  |  | 7 |  |  | 1,798 |
Operating lease right-of-use assets, net | 193 |  |  | 5 |  |  | 198 |  |  | 176 |  |  | — |  |  | 176 |
Other noncurrent assets | 122 |  |  | (1) |  |  | 121 |  |  | 94 |  |  | 1 |  |  | 95 |
Total Assets | 9,220 |  |  | 19 |  |  | 9,239 |  |  | 9,342 |  |  | 8 |  |  | 9,350 |
Accounts payable | 268 |  |  | (6) |  |  | 262 |  |  | 305 |  |  | (3) |  |  | 302 |
Accrued liabilities | 679 |  |  | 81 |  |  | 760 |  |  | 653 |  |  | 59 |  |  | 712 |
Income taxes payable | 57 |  |  | — |  |  | 57 |  |  | 60 |  |  | (1) |  |  | 59 |
Total Current Liabilities | 1,186 |  |  | 75 |  |  | 1,261 |  |  | 1,317 |  |  | 55 |  |  | 1,372 |
Operating lease liabilities | 145 |  |  | 4 |  |  | 149 |  |  | 130 |  |  | — |  |  | 130 |
Deferred income taxes | 408 |  |  | (17) |  |  | 391 |  |  | 393 |  |  | (12) |  |  | 381 |
Total Liabilities | 4,177 |  |  | 65 |  |  | 4,242 |  |  | 4,372 |  |  | 43 |  |  | 4,415 |
Retained earnings | 1,560 |  |  | (46) |  |  | 1,514 |  |  | 1,233 |  |  | (35) |  |  | 1,198 |
Total Dentsply Sirona Equity | 5,042 |  |  | (46) |  |  | 4,996 |  |  | 4,967 |  |  | (35) |  |  | 4,932 |
Total Equity | 5,043 |  |  | (46) |  |  | 4,997 |  |  | 4,970 |  |  | (35) |  |  | 4,935 |
Total Liabilities and Equity | 9,220 |  |  | 19 |  |  | 9,239 |  |  | 9,342 |  |  | 8 |  |  | 9,350 |
CONSOLIDATED STATEMENT OF CASH FLOWS
| Year Ended December 31, 2021 |  | Year Ended December 31, 2020 |  | Year Ended December 31, 2019
(in millions) | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) | $ | 421 |  |  | $ | (10) |  |  | $ | 411 |  |  | $ | (83) |  |  | $ | 10 |  |  | $ | (73) |  |  | $ | 263 |  |  | $ | (7) |  |  | $ | 256 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred income taxes | (20) |  |  | (5) |  |  | (25) |  |  | (64) |  |  | 2 |  |  | (62) |  |  | (37) |  |  | (3) |  |  | (40) |
Other non-cash (income) expense | 34 |  |  | — |  |  | 34 |  |  | 2 |  |  | 1 |  |  | 3 |  |  | (6) |  |  | 12 |  |  | 6 |
Changes in operating assets and liabilities, net of acquisitions: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts and notes receivable-trade, net | (109) |  |  | (8) |  |  | (117) |  |  | 126 |  |  | 5 |  |  | 131 |  |  | (91) |  |  | 1 |  |  | (90) |
Inventories, net | (63) |  |  | (1) |  |  | (64) |  |  | 124 |  |  | (1) |  |  | 123 |  |  | 14 |  |  | (3) |  |  | 11 |
Prepaid expenses and other current assets, net | (35) |  |  | 3 |  |  | (32) |  |  | 42 |  |  | (3) |  |  | 39 |  |  | 13 |  |  | (1) |  |  | 12 |
Accounts payable | (46) |  |  | (3) |  |  | (49) |  |  | (23) |  |  | (5) |  |  | (28) |  |  | 26 |  |  | 1 |  |  | 27 |
Accrued liabilities | 78 |  |  | 22 |  |  | 100 |  |  | (17) |  |  | 7 |  |  | (10) |  |  | 45 |  |  | 14 |  |  | 59 |
Income taxes | 17 |  |  | — |  |  | 17 |  |  | (39) |  |  | (2) |  |  | (41) |  |  | (16) |  |  | 2 |  |  | (14) |
Other noncurrent liabilities | 10 |  |  | 2 |  |  | 12 |  |  | (15) |  |  | — |  |  | (15) |  |  | (2) |  |  | (10) |  |  | (12) |
Net cash provided by operating activities | 657 |  |  | — |  |  | 657 |  |  | 635 |  |  | 14 |  |  | 649 |  |  | 633 |  |  | 6 |  |  | 639 |
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other financing activities, net | (36) |  |  | — |  |  | (36) |  |  | (12) |  |  | (14) |  |  | (26) |  |  | (34) |  |  | (6) |  |  | (40) |
Net cash (used in) provided by financing activities | (379) |  |  | — |  |  | (379) |  |  | 490 |  |  | (14) |  |  | 476 |  |  | (466) |  |  | (6) |  |  | (472) |
The following tables present the effect of correcting the Company’s previously issued quarterly financial statements for the accounting errors described in Note 1, Significant Accounting Policies and Restatement:
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended March 31, 2021 |  | Three Months Ended March 31, 2020
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 1,027 |  |  | $ | (1) |  |  | $ | 1,026 |  |  | $ | 874 |  |  | $ | 7 |  |  | $ | 881 |
Cost of products sold |  | 448 |  |  | (1) |  |  | 447 |  |  | 406 |  |  | — |  |  | 406 |
Gross profit |  | 579 |  |  | — |  |  | 579 |  |  | 468 |  |  | 7 |  |  | 475 |
Selling, general, and administrative expenses |  | 385 |  |  | 1 |  |  | 386 |  |  | 359 |  |  | (2) |  |  | 357 |
Research and development expenses |  | 37 |  |  | 3 |  |  | 40 |  |  | 34 |  |  | 2 |  |  | 36 |
Goodwill impairment |  | — |  |  | — |  |  | — |  |  | 157 |  |  | — |  |  | 157 |
Restructuring and other costs |  | 3 |  |  | — |  |  | 3 |  |  | 43 |  |  | (1) |  |  | 42 |
Operating income (loss) |  | 154 |  |  | (4) |  |  | 150 |  |  | (125) |  |  | 8 |  |  | (117) |
Other income and expenses: |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  | 14 |  |  | — |  |  | 14 |  |  | 7 |  |  | (1) |  |  | 6 |
Other expense (income), net |  | (9) |  |  | — |  |  | (9) |  |  | (2) |  |  | 1 |  |  | (1) |
Income (loss) before income taxes |  | 149 |  |  | (4) |  |  | 145 |  |  | (130) |  |  | 8 |  |  | (122) |
Provision for income taxes |  | 32 |  |  | 1 |  |  | 33 |  |  | 10 |  |  | 2 |  |  | 12 |
Net income (loss) |  | 117 |  |  | (5) |  |  | 112 |  |  | (140) |  |  | 6 |  |  | (134) |
Less: Net income (loss) attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income (loss) attributable to Dentsply Sirona |  | $ | 117 |  |  | $ | (5) |  |  | $ | 112 |  |  | $ | (140) |  |  | $ | 6 |  |  | $ | (134) |
Net income (loss) per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.53 |  |  | $ | (0.02) |  |  | $ | 0.51 |  |  | $ | (0.63) |  |  | $ | 0.02 |  |  | $ | (0.61) |
Diluted |  | $ | 0.53 |  |  | $ | (0.02) |  |  | $ | 0.51 |  |  | $ | (0.63) |  |  | $ | 0.02 |  |  | $ | (0.61) |
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended June 30, 2021 |  | Three Months Ended June 30, 2020
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 1,067 |  |  | $ | (5) |  |  | $ | 1,062 |  |  | $ | 491 |  |  | $ | 8 |  |  | $ | 499 |
Cost of products sold |  | 469 |  |  | (2) |  |  | 467 |  |  | 315 |  |  | 2 |  |  | 317 |
Gross profit |  | 598 |  |  | (3) |  |  | 595 |  |  | 176 |  |  | 6 |  |  | 182 |
Selling, general, and administrative expenses |  | 398 |  |  | (5) |  |  | 393 |  |  | 261 |  |  | (2) |  |  | 259 |
Research and development expenses |  | 40 |  |  | 3 |  |  | 43 |  |  | 18 |  |  | 2 |  |  | 20 |
Restructuring and other costs |  | 5 |  |  | — |  |  | 5 |  |  | 1 |  |  | 1 |  |  | 2 |
Operating income (loss) |  | 155 |  |  | (1) |  |  | 154 |  |  | (104) |  |  | 5 |  |  | (99) |
Other income and expenses: |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  | 16 |  |  | (1) |  |  | 15 |  |  | 11 |  |  | — |  |  | 11 |
Other expense (income), net |  | 5 |  |  | 3 |  |  | 8 |  |  | 5 |  |  | (1) |  |  | 4 |
Income (loss) before income taxes |  | 134 |  |  | (3) |  |  | 131 |  |  | (120) |  |  | 6 |  |  | (114) |
Provision (benefit) for income taxes |  | 35 |  |  | — |  |  | 35 |  |  | (24) |  |  | 2 |  |  | (22) |
Net income (loss) |  | 99 |  |  | (3) |  |  | 96 |  |  | (96) |  |  | 4 |  |  | (92) |
Less: Net income (loss) attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | (1) |
Net income (loss) attributable to Dentsply Sirona |  | $ | 99 |  |  | $ | (3) |  |  | $ | 96 |  |  | $ | (95) |  |  | $ | 4 |  |  | $ | (91) |
Net income (loss) per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.45 |  |  | $ | (0.01) |  |  | $ | 0.44 |  |  | $ | (0.44) |  |  | $ | 0.02 |  |  | $ | (0.42) |
Diluted |  | $ | 0.45 |  |  | $ | (0.02) |  |  | $ | 0.43 |  |  | $ | (0.44) |  |  | $ | 0.02 |  |  | $ | (0.42) |
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended September 30, 2021 |  | Three Months Ended September 30, 2020
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 1,069 |  |  | $ | (29) |  |  | $ | 1,040 |  |  | $ | 895 |  |  | $ | (12) |  |  | $ | 883 |
Cost of products sold |  | 478 |  |  | (7) |  |  | 471 |  |  | 453 |  |  | (2) |  |  | 451 |
Gross profit |  | 591 |  |  | (22) |  |  | 569 |  |  | 442 |  |  | (10) |  |  | 432 |
Selling, general, and administrative expenses |  | 394 |  |  | 1 |  |  | 395 |  |  | 315 |  |  | (2) |  |  | 313 |
Research and development expenses |  | 35 |  |  | 4 |  |  | 39 |  |  | 27 |  |  | 2 |  |  | 29 |
Restructuring and other costs |  | 3 |  |  | — |  |  | 3 |  |  | 18 |  |  | — |  |  | 18 |
Operating income |  | 159 |  |  | (27) |  |  | 132 |  |  | 82 |  |  | (10) |  |  | 72 |
Interest expense, net |  | 13 |  |  | 1 |  |  | 14 |  |  | 14 |  |  | — |  |  | 14 |
Other expense (income), net |  | 8 |  |  | (3) |  |  | 5 |  |  | 1 |  |  | — |  |  | 1 |
Income before income taxes |  | 138 |  |  | (25) |  |  | 113 |  |  | 67 |  |  | (10) |  |  | 57 |
Provision for income taxes |  | 35 |  |  | (6) |  |  | 29 |  |  | 13 |  |  | (4) |  |  | 9 |
Net income |  | 103 |  |  | (19) |  |  | 84 |  |  | 54 |  |  | (6) |  |  | 48 |
Net income attributable to Dentsply Sirona |  | $ | 103 |  |  | $ | (19) |  |  | $ | 84 |  |  | $ | 53 |  |  | $ | (6) |  |  | $ | 47 |
Net income per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.47 |  |  | $ | (0.08) |  |  | $ | 0.39 |  |  | $ | 0.25 |  |  | $ | (0.03) |  |  | $ | 0.22 |
Diluted |  | $ | 0.47 |  |  | $ | (0.09) |  |  | $ | 0.38 |  |  | $ | 0.25 |  |  | $ | (0.03) |  |  | $ | 0.22 |
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended December 31, 2021 |  | Three Months Ended December 31, 2020
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 1,088 |  |  | $ | 15 |  |  | $ | 1,103 |  |  | $ | 1,082 |  |  | $ | (6) |  |  | $ | 1,076 |
Cost of products sold |  | 495 |  |  | 4 |  |  | 499 |  |  | 511 |  |  | (2) |  |  | 509 |
Gross profit |  | 593 |  |  | 11 |  |  | 604 |  |  | 571 |  |  | (4) |  |  | 567 |
Selling, general, and administrative expenses |  | 374 |  |  | 3 |  |  | 377 |  |  | 377 |  |  | (4) |  |  | 373 |
Research and development expenses |  | 59 |  |  | (10) |  |  | 49 |  |  | 44 |  |  | (6) |  |  | 38 |
Restructuring and other costs |  | 6 |  |  | — |  |  | 6 |  |  | 15 |  |  | — |  |  | 15 |
Operating income |  | 154 |  |  | 18 |  |  | 172 |  |  | 135 |  |  | 6 |  |  | 141 |
Other income and expenses: |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  | 12 |  |  | — |  |  | 12 |  |  | 15 |  |  | — |  |  | 15 |
Other expense (income), net |  | 4 |  |  | — |  |  | 4 |  |  | (3) |  |  | — |  |  | (3) |
Income before income taxes |  | 138 |  |  | 18 |  |  | 156 |  |  | 123 |  |  | 6 |  |  | 129 |
Provision for income taxes |  | 36 |  |  | 1 |  |  | 37 |  |  | 24 |  |  | — |  |  | 24 |
Net income |  | 102 |  |  | 17 |  |  | 119 |  |  | 99 |  |  | 6 |  |  | 105 |
Less: Net income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income attributable to Dentsply Sirona |  | $ | 102 |  |  | $ | 17 |  |  | $ | 119 |  |  | $ | 99 |  |  | $ | 6 |  |  | $ | 105 |
Net income per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.47 |  |  | $ | 0.08 |  |  | $ | 0.55 |  |  | $ | 0.45 |  |  | $ | 0.03 |  |  | $ | 0.48 |
Diluted |  | $ | 0.47 |  |  | $ | 0.07 |  |  | $ | 0.54 |  |  | $ | 0.45 |  |  | $ | 0.03 |  |  | $ | 0.48 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months Ended March 31, 2021 |  | Three Months Ended March 31, 2020
(in millions) | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net income (loss) | $ | 117 |  |  | $ | (5) |  |  | $ | 112 |  |  | $ | (140) |  |  | $ | 6 |  |  | $ | (134) |
Total comprehensive income | 27 |  |  | (5) |  |  | 22 |  |  | (252) |  |  | 6 |  |  | (246) |
Comprehensive income attributable to Dentsply Sirona | $ | 27 |  |  | $ | (5) |  |  | $ | 22 |  |  | $ | (252) |  |  | $ | 6 |  |  | $ | (246) |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months Ended June 30, 2021 |  | Three Months Ended June 30, 2020
(in millions) | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net income (loss) | $ | 99 |  |  | $ | (3) |  |  | $ | 96 |  |  | $ | (96) |  |  | $ | 4 |  |  | $ | (92) |
Total comprehensive income | 142 |  |  | (3) |  |  | 139 |  |  | (28) |  |  | 4 |  |  | (24) |
Comprehensive income attributable to Dentsply Sirona | $ | 142 |  |  | $ | (3) |  |  | $ | 139 |  |  | $ | (28) |  |  | $ | 4 |  |  | $ | (24) |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|  | Three Months Ended September 30, 2021 |  | Three Months Ended September 30, 2020
(in millions) |  | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Net income |  | $ | 103 |  |  | $ | (19) |  |  | $ | 84 |  |  | $ | 54 |  |  | $ | (6) |  |  | $ | 48 |
Total comprehensive income |  | 47 |  |  | (19) |  |  | 28 |  |  | 121 |  |  | (6) |  |  | 115 |
Comprehensive income attributable to Dentsply Sirona |  | $ | 47 |  |  | $ | (19) |  |  | $ | 28 |  |  | $ | 121 |  |  | $ | (6) |  |  | $ | 115 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months Ended December 31, 2021 |  | Three Months Ended December 31, 2020
(in millions) | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Net income (loss) | $ | 102 |  |  | $ | 17 |  |  | $ | 119 |  |  | $ | 99 |  |  | $ | 6 |  |  | $ | 105 |
Total comprehensive income | 75 |  |  | 17 |  |  | 92 |  |  | 213 |  |  | 8 |  |  | 221 |
Comprehensive income attributable to Dentsply Sirona | $ | 75 |  |  | $ | 17 |  |  | $ | 92 |  |  | $ | 213 |  |  | $ | 8 |  |  | $ | 221 |
Schedule of Quarterly Financial Information |
2021 |  | Net Sales |  | Gross Profit |  |  |  | Operating Income (Loss) |  | Net (Loss) Income attributable to Dentsply Sirona |  | Net (Loss) Income per Common Share - Basic |  | Net (Loss) Income per Common Share - Diluted |  | Cash Dividends Declared per Common Share
First Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,027 |  |  | $ | 579 |  |  |  |  | $ | 154 |  |  | $ | 117 |  |  | $ | 0.53 |  |  | $ | 0.53 |  |  | $ | 0.1000 |
Adjustment |  | (1) |  |  | — |  |  |  |  | (4) |  |  | (5) |  |  | (0.02) |  |  | (0.02) |  |  | — |
As revised |  | $ | 1,026 |  |  | $ | 579 |  |  |  |  | $ | 150 |  |  | $ | 112 |  |  | $ | 0.51 |  |  | $ | 0.51 |  |  | $ | 0.1000 |
Second Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,067 |  |  | $ | 598 |  |  |  |  | $ | 155 |  |  | $ | 99 |  |  | $ | 0.45 |  |  | $ | 0.45 |  |  | $ | 0.1100 |
Adjustment |  | (5) |  |  | (3) |  |  |  |  | (1) |  |  | (3) |  |  | (0.01) |  |  | (0.02) |  |  | — |
As revised |  | $ | 1,062 |  |  | $ | 595 |  |  |  |  | $ | 154 |  |  | $ | 96 |  |  | $ | 0.44 |  |  | $ | 0.43 |  |  | $ | 0.1100 |
Third Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,069 |  |  | $ | 591 |  |  |  |  | $ | 159 |  |  | $ | 103 |  |  | $ | 0.47 |  |  | $ | 0.47 |  |  | $ | 0.1100 |
Adjustment |  | (29) |  |  | (22) |  |  |  |  | (27) |  |  | (19) |  |  | (0.08) |  |  | (0.09) |  |  | — |
As restated |  | $ | 1,040 |  |  | $ | 569 |  |  |  |  | $ | 132 |  |  | $ | 84 |  |  | $ | 0.39 |  |  | $ | 0.38 |  |  | $ | 0.1100 |
Fourth Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,088 |  |  | $ | 593 |  |  |  |  | $ | 154 |  |  | $ | 102 |  |  | $ | 0.47 |  |  | $ | 0.47 |  |  | $ | 0.1100 |
Adjustment |  | 15 |  |  | 11 |  |  |  |  | 18 |  |  | 17 |  |  | 0.08 |  |  | 0.07 |  |  | — |
As restated |  | $ | 1,103 |  |  | $ | 604 |  |  |  |  | $ | 172 |  |  | $ | 119 |  |  | $ | 0.55 |  |  | $ | 0.54 |  |  | $ | 0.1100 |
Rounding, As previously issued |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 0.01 |  |  | (0.01) |  |  | — |
Rounding: Adjustment |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | (0.02) |  |  | 0.02 |  |  | — |
Rounding, As revised |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | (0.01) |  |  | 0.01 |  |  | — |
Total Year |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 4,251 |  |  | $ | 2,361 |  |  |  |  | $ | 622 |  |  | $ | 421 |  |  | $ | 1.93 |  |  | $ | 1.91 |  |  | $ | 0.4300 |
Adjustment |  | (20) |  |  | (14) |  |  |  |  | (14) |  |  | (10) |  |  | (0.05) |  |  | (0.04) |  |  | — |
As revised |  | $ | 4,231 |  |  | $ | 2,347 |  |  |  |  | $ | 608 |  |  | $ | 411 |  |  | $ | 1.88 |  |  | $ | 1.87 |  |  | $ | 0.4300 |
2020 |  | Net Sales |  | Gross Profit |  |  |  | Operating Income (Loss) |  | Net (Loss) Income attributable to Dentsply Sirona |  | Net (Loss) Income per Common Share - Basic |  | Net (Loss) Income per Common Share - Diluted |  | Cash Dividends Declared per Common Share
First Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 874 |  |  | $ | 468 |  |  |  |  | $ | (125) |  |  | $ | (140) |  |  | $ | (0.63) |  |  | $ | (0.63) |  |  | $ | 0.1000 |
Adjustment |  | 7 |  |  | 7 |  |  |  |  | 8 |  |  | 6 |  |  | 0.02 |  |  | 0.02 |  |  | — |
As revised |  | $ | 881 |  |  | $ | 475 |  |  |  |  | $ | (117) |  |  | $ | (134) |  |  | $ | (0.61) |  |  | $ | (0.61) |  |  | $ | 0.1000 |
Second Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 491 |  |  | $ | 176 |  |  |  |  | $ | (104) |  |  | $ | (95) |  |  | $ | (0.44) |  |  | $ | (0.44) |  |  | $ | 0.1000 |
Adjustment |  | 8 |  |  | 6 |  |  |  |  | 5 |  |  | 4 |  |  | 0.02 |  |  | 0.02 |  |  | — |
As revised |  | $ | 499 |  |  | $ | 182 |  |  |  |  | $ | (99) |  |  | $ | (91) |  |  | $ | (0.42) |  |  | $ | (0.42) |  |  | $ | 0.1000 |
Third Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 895 |  |  | $ | 442 |  |  |  |  | $ | 82 |  |  | $ | 53 |  |  | $ | 0.25 |  |  | $ | 0.25 |  |  | $ | 0.1000 |
Adjustment |  | (12) |  |  | (10) |  |  |  |  | (10) |  |  | (6) |  |  | (0.03) |  |  | (0.03) |  |  | — |
As revised |  | $ | 883 |  |  | $ | 432 |  |  |  |  | $ | 72 |  |  | $ | 47 |  |  | $ | 0.22 |  |  | $ | 0.22 |  |  | $ | 0.1000 |
Fourth Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,082 |  |  | $ | 571 |  |  |  |  | $ | 135 |  |  | $ | 99 |  |  | $ | 0.45 |  |  | $ | 0.45 |  |  | $ | 0.1000 |
Adjustment |  | (6) |  |  | (4) |  |  |  |  | 6 |  |  | 6 |  |  | 0.03 |  |  | 0.03 |  |  | — |
As revised |  | $ | 1,076 |  |  | $ | 567 |  |  |  |  | $ | 141 |  |  | $ | 105 |  |  | $ | 0.48 |  |  | $ | 0.48 |  |  | $ | 0.1000 |
Rounding, As previously issued |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | (0.01) |  |  | (0.01) |  |  | — |
Rounding, Adjustment |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 0.01 |  |  | 0.01 |  |  | — |
Total Year |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 3,342 |  |  | $ | 1,657 |  |  |  |  | $ | (12) |  |  | $ | (83) |  |  | $ | (0.38) |  |  | $ | (0.38) |  |  | $ | 0.4000 |
Adjustment |  | (3) |  |  | (1) |  |  |  |  | 9 |  |  | 10 |  |  | 0.05 |  |  | 0.05 |  |  | — |
As revised |  | $ | 3,339 |  |  | $ | 1,656 |  |  |  |  | $ | (3) |  |  | $ | (73) |  |  | $ | (0.33) |  |  | $ | (0.33) |  |  | $ | 0.4000 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=124502072&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration